Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

Abroad (travel likely)RecruitingPHASE1

Conditions

Atopic Dermatitis (AD) · Psoriasis (PsO)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Red River Research Partners, Fargo, North Dakota, United States
Clinical Investigations of Texas, Dallas, Texas, United States
Contact: Study coordinator (Sangram Raut, PhD) · info@clinicalinvestigationsoftexas.com · 9725991530
Triumpharma Clinical Research Unit at AlEssra Hospital, Amman, Jordan, Jordan

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease

Autoimmune Diseases · Rheumatoid Arthritis (RA) · Psoriatic Arthritis (PsA)

Abroad (travel likely)RecruitingPHASE1

Charlestown, Australia · Birtinya, Australia

Skin Microbial Ecology in Atopic Dermatitis

Atopic Dermatitis · Psoriasis · Healthy

Abroad (travel likely)Recruiting

Rochester, United States

SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)

Chronic Spontaneous Urticaria (CSU) · Hidradenitis Suppurativa (HS) · Psoriasis (PsO)

Abroad (travel likely)Recruiting

Nijmegen, Netherlands · Maastricht, Netherlands

A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)

Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE1

Irvine, United States · New York, United States